MedPath

Realization for regenerative therapy of middle ear mucosa by using autologous nasal mucosal epithelial cell sheets

Phase 2
Completed
Conditions
Middle ear cholesteatoma, Adhesive otitis media
Registration Number
JPRN-jRCT1090220316
Lead Sponsor
Hiromi Kojima
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
10
Inclusion Criteria

Patients with middle ear cholesteatoma or adhesive otitis media requiring tympanoplasty.

Exclusion Criteria

-Patients with critical illness as immunity deficiency, heart disease, renal disease, lever disease, diabetes mellitus, asthma, malignant tumor, etc.
-Patients with infectious disease as HBV, HCV, HIV, HTLV, FTA-ABS.
-pregnant women, women suspected of being pregnant, and nursing women.
-Patient with some complications (Doctor's judgment).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath